Clinical trials
Recruiting Phase 1 Lymphoma, Large B-Cell, Diffuse trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 10 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 3 |
| National Cancer Institute (NCI) | 3 |
| Nurix Therapeutics, Inc. | 3 |
| Eli Lilly and Company | 2 |
| University of Utah | 2 |
| AIDS Malignancy Consortium | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Accutar Biotechnology Inc | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Aurigene Discovery Technologies Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 44 |
| Lymphoma, Mantle-Cell | 20 |
| Lymphoma, Follicular | 18 |
| Lymphoma, Non-Hodgkin | 16 |
| Lymphoma, B-Cell, Marginal Zone | 14 |
| Lymphoma, B-Cell | 11 |
| Waldenstrom Macroglobulinemia | 8 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Burkitt Lymphoma | 4 |
| Lymphoma | 4 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.